	A 53-Year-Old Male Smoker With Advanced Oral Squamous Cell Carcinoma Associated With Paraneoplastic Leukemoid Reaction. Am J Case Rep Yeh CY. PMID: 41838641 [PubMed - indexed for MEDLINE]
	Neoadjuvant systemic immunotherapy for skin cancers. Cancer Dessinioti C, Stratigos A. PMID: 41838427 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial. Ann Surg Oncol Mor E, Apte S, Bressel M, Broman KK, Hieken TJ, Olofsson Bagge R, Berman RS, Lee AY, Kuijpers AM, Ollila DW, van Akkooi ACJ, Zager JS, Gyorki DE. PMID: 41838356 [PubMed - as supplied by publisher]
	Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma. Discov Oncol Urbonas V, Dulskas A. PMID: 41838305 [PubMed - as supplied by publisher]
	Metformin Use and Development of Esophageal Squamous Cell Carcinoma. JAMA Netw Open Xie SH, Santoni G, Birgisson H, von Euler-Chelpin M, Kauppila JH, Ness-Jensen E, Lagergren J. PMID: 41837999 [PubMed - indexed for MEDLINE]
	Quercetin's Multifaceted Role in Alzheimer's Disease, Melanoma, and Tuberculosis: A Systematic Review with Preclinical Insights. Curr Pharm Des Pratap Swain M, Mohanty S, Gupta N, Mukherjee T, Kumar Singh S, Pattnaik A. PMID: 41837588 [PubMed - as supplied by publisher]
	Efficacy and safety of neoadjuvant immunotherapy in locally advanced resectable esophageal squamous cell carcinoma: a network meta-analysis and real-world study. Front Immunol Sun M, Yang P, Qi L, Yang T, Wang W, Yu Y, Zhang J, Zhu B, Li Y. PMID: 41836437 [PubMed - indexed for MEDLINE]
	Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysis. Front Immunol Yang K, Shang W, Wang L, He J, Zuo Z, Dai Q, Liu J, Zeng L, Yang Y, Cao F, Yu Y, Wan G. PMID: 41836421 [PubMed - indexed for MEDLINE]
	Surgical treatment of the patient with locally advanced esophageal cancer and concurrent thymoma after neoadjuvant therapy: a case report. Front Immunol Zhang QX, Liu H, Xu J, Zeng T, Zhang J, Ren XF, Li D, Guo Q, Liu T. PMID: 41836409 [PubMed - indexed for MEDLINE]
	Immunotherapy-induced sialadenitis: sjÃ¶gren's syndrome or a new sialadenitis. Front Immunol Song S, Lao Z, Yu R, Yu S, Li P, Yan Y, Yang L, Liao G, Wang Y, Zhang S. PMID: 41836391 [PubMed - indexed for MEDLINE]
	A combined immune-nutritional score as a prognostic indicator in neoadjuvant-treated esophageal squamous cell carcinoma. Front Immunol Xie Q, Zhan J, Ye X, Huang C, Chen C, Zheng B, Xu G, Yang Z, Zhu Y. PMID: 41836385 [PubMed - indexed for MEDLINE]
	Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis. EXCLI J Omar Khan O. PMID: 41834910 [PubMed]
	Implications of Glomus Tumor Pathology and Pain Mechanism for Surgical Treatment. Ann Ital Chir Yu X, Ma Y, Xu Y, Wang D. PMID: 41834553 [PubMed - indexed for MEDLINE]
	Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study. Int J Cancer Gutzmer R, Weichenthal M, Eigentler T, Mohr P, Sickmann T, Dücker P, Gebhardt C, Haferkamp S, Kähler KC, Meier F, Pföhler C, Sindrilaru A, Terheyden P, von Wasielewski I, Ugurel S, Ulrich J, Utikal J, Weishaupt C, Schadendorf D. PMID: 41833546 [PubMed - as supplied by publisher]
	High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerability. Cancer Fields BC, Traweek RS, Jiang K, Witt RG, Damania A, Chiang YJ, Ajami N, Nassif-Haddad E, Keung EZ, Chelvanambi M, Zhang X, Peterson CB, Wargo JA, Daniel CR, Roland CL, Holder AM. PMID: 41832741 [PubMed - indexed for MEDLINE]
	Precision Design in Cancer Treatment: Cucurbitacin E Modulates AMPK, PGK1, and PKM2 to Optimize Radiation Efficacy in Melanoma. Curr Pharm Des Abdelrhman IG, Hamdy AM, Abdalla Hussein M, Emara AA, Mohamed SF, Azmy Boshra S, Atef Mahmoud A. PMID: 41832669 [PubMed - as supplied by publisher]
	Exploring risk factors and survival rates in invasive cervical carcinoma: New perspectives. Tunis Med Belhadj A, Boumeddane YK, Meddah D, Sahraoui T. PMID: 41832650 [PubMed - indexed for MEDLINE]
	CD27 expression is a clinically accessible biomarker for predicting immunotherapy response in melanoma. NPJ Precis Oncol Xia P, Yang H, Yu P, Miao Y, Tang L, Wang Y, Li B, Wang Z, Jiang G, Chen K, Li S, Yang M. PMID: 41832290 [PubMed - as supplied by publisher]
	Cutaneous Melanoma: Association of Histopathological Subtypes and Breslow Thickness with Occupation and Residence in An observational study of 2,486 patients. Actas Dermosifiliogr Angel-Baldo J, Stoicev O, Barceló C, Matas-Nadal C, Soria X, Gatius S, Murata P, Nagore E, Marti RM. PMID: 41831776 [PubMed - as supplied by publisher]
	Frailty and survival outcomes in veterans with invasive cutaneous melanoma: A Veterans Affairs Cancer Registry retrospective cohort study. J Am Acad Dermatol Huhmann LB, Hwang JC, Kim DY, Nannini K, Do NV, Gaziano JM, Wheless LE, Fillmore NR, Hartman RI. PMID: 41831612 [PubMed - as supplied by publisher]

Articles 1 - 20 / 141962

Page 1 of 7099



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy